Cited In for PMID: 29078805

Year	Number of Results
2017	1
2018	6
2019	9
2020	20
2021	8
2022	11
2023	9
2024	4

1

CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2 ^N141I neurons.

Ortiz-Virumbrales M, Moreno CL, Kruglikov I, Marazuela P, Sproul A, Jacob S, Zimmer M, Paull D, Zhang B, Schadt EE, Ehrlich ME, Tanzi RE, Arancio O, Noggle S, Gandy S. Ortiz-Virumbrales M, et al. Acta Neuropathol Commun. 2017 Oct 27;5(1):77. doi: 10.1186/s40478-017-0475-z. Acta Neuropathol Commun. 2017. PMID: 29078805 Free PMC article.

2

Application of CRISPR/Cas9 System in the Treatment of Alzheimer's Disease and Neurodegenerative Diseases.

Rahimi A, Sameei P, Mousavi S, Ghaderi K, Hassani A, Hassani S, Alipour S. Rahimi A, et al. Mol Neurobiol. 2024 Apr 19. doi: 10.1007/s12035-024-04143-2. Online ahead of print. Mol Neurobiol. 2024. PMID: 38639864 Review.

3

Human stem cell transplantation models of Alzheimer's disease.

Ifediora N, Canoll P, Hargus G. Ifediora N, et al. Front Aging Neurosci. 2024 Feb 21;16:1354164. doi: 10.3389/fnagi.2024.1354164. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38450383 Free PMC article. Review.

4

Application of CRISPR/Cas9 in the management of Alzheimer's disease and Parkinson's disease: a review.

Thapar N, Eid MAF, Raj N, Kantas T, Billing HS, Sadhu D. Thapar N, et al. Ann Med Surg (Lond). 2023 Nov 16;86(1):329-335. doi: 10.1097/MS9.0000000000001500. eCollection 2024 Jan. Ann Med Surg (Lond). 2023. PMID: 38222734 Free PMC article. Review.

5

iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype.

Sullivan MA, Lane SD, McKenzie ADJ, Ball SR, Sunde M, Neely GG, Moreno CL, Maximova A, Werry EL, Kassiou M. Sullivan MA, et al. J Neuroinflammation. 2024 Jan 4;21(1):7. doi: 10.1186/s12974-023-02951-2. J Neuroinflammation. 2024. PMID: 38178159 Free PMC article.

6

Efficient gene editing in induced pluripotent stem cells enabled by an inducible adenine base editor with tunable expression.

Nandy K, Babu D, Rani S, Joshi G, Ijee S, George A, Palani D, Premkumar C, Rajesh P, Vijayanand S, David E, Murugesan M, Velayudhan SR. Nandy K, et al. Sci Rep. 2023 Dec 11;13(1):21953. doi: 10.1038/s41598-023-42174-2. Sci Rep. 2023. PMID: 38081875 Free PMC article.

7

CRISPR/Cas9 genome editing for neurodegenerative diseases.

Nouri Nojadeh J, Bildiren Eryilmaz NS, Ergüder BI. Nouri Nojadeh J, et al. EXCLI J. 2023 Jul 3;22:567-582. doi: 10.17179/excli2023-6155. eCollection 2023. EXCLI J. 2023. PMID: 37636024 Free PMC article. Review.

8

Vector enabled CRISPR gene editing - A revolutionary strategy for targeting the diversity of brain pathologies.

Forgham H, Liu L, Zhu J, Javed I, Cai W, Qiao R, Davis TP. Forgham H, et al. Coord Chem Rev. 2023 Jul 15;487:215172. doi: 10.1016/j.ccr.2023.215172. Epub 2023 Apr 20. Coord Chem Rev. 2023. PMID: 37305445

9

Gene Repair of iPSC Line with GARS (G294R) Mutation of CMT2D Disease by CRISPR/Cas9.

Lu PJ, Zhang P, Liu YC, Jing N, Guo YN, Wang PS, Su LL, Guo Q, Ma Q, Xu YM, Zhang ST. Lu PJ, et al. Curr Med Sci. 2023 Apr;43(2):261-267. doi: 10.1007/s11596-023-2707-8. Epub 2023 Mar 18. Curr Med Sci. 2023. PMID: 36932303

10

The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.

Sahlgren Bendtsen KM, Hall VJ. Sahlgren Bendtsen KM, et al. Cells. 2023 Jan 27;12(3):420. doi: 10.3390/cells12030420. Cells. 2023. PMID: 36766763 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

61 results

Results by year